Cipher Pharmaceuticals Inc.
CPH.TO
TSX
Weiss Ratings | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B- | |||
Rating Factors | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.52 | |||
Price History | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.41% | |||
30-Day Total Return | -13.43% | |||
60-Day Total Return | -18.49% | |||
90-Day Total Return | -22.06% | |||
Year to Date Total Return | -15.30% | |||
1-Year Total Return | 70.46% | |||
2-Year Total Return | 218.95% | |||
3-Year Total Return | 537.89% | |||
5-Year Total Return | 1,378.05% | |||
52-Week High % Change | -42.66% | |||
52-Week Low % Change | 69.27% | |||
Price | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $19.69 | |||
52-Week Low Price | $6.67 | |||
52-Week Low Price (Date) | Mar 15, 2024 | |||
52-Week High Price (Date) | Aug 29, 2024 | |||
Valuation | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 200.80M | |||
Enterprise Value | 230.12M | |||
Price/Earnings (TTM) | 17.82 | |||
Earnings Per Share (TTM) | 0.63 | |||
Earnings Per Share Growth | -49.60% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 10.96 | |||
Price/Book (Q) | 2.92 | |||
Enterprise Value/Revenue (TTM) | 8.70 | |||
Price | $12.12 | |||
Enterprise Value/EBITDA (TTM) | 18.30 | |||
Enterprise Value/EBIT | 23.28 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 25.69M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 905 602 5840 | |||
Address | 5750 Explorer Drive Mississauga, ON L4W 0A9 | |||
Website | www.cipherpharma.com | |||
Country | Canada | |||
Year Founded | 2000 | |||
Profitability | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 37.34% | |||
Profit Margin | 59.92% | |||
Management Effectiveness | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 5.06% | |||
Return on Equity | 17.98% | |||
Income Statement | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 26.46M | |||
Total Revenue (TTM) | 26.46M | |||
Revenue Per Share | $1.03 | |||
Gross Profit (TTM) | 21.38M | |||
EBITDA (TTM) | 12.57M | |||
EBIT (TTM) | 9.88M | |||
Net Income (TTM) | 15.86M | |||
Net Income Avl. to Common (TTM) | 15.86M | |||
Total Revenue Growth (Q YOY) | 70.90% | |||
Earnings Growth (Q YOY) | -95.97% | |||
EPS Diluted (TTM) | 0.63 | |||
EPS Diluted Growth (Q YOY) | -96.30% | |||
Balance Sheet | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 9.52M | |||
Cash Per Share (Q) | $0.37 | |||
Total Current Assets (Q) | 29.06M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 98.86M | |||
Current Ratio (Q) | 2.003 | |||
Book Value Per Share (Q) | $3.86 | |||
Total Assets (Q) | 153.86M | |||
Total Current Liabilities (Q) | 14.51M | |||
Total Debt (Q) | 40.75M | |||
Total Liabilities (Q) | 55.00M | |||
Total Common Equity (Q) | 98.86M | |||
Cash Flow | CPH.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -80.18M | |||
Cash from Financing (TTM) | 34.46M | |||
Net Change in Cash (TTM) | -32.56M | |||
Levered Free Cash Flow (TTM) | -78.71M | |||
Cash from Operations (TTM) | 13.08M | |||